edatrexate has been researched along with Local Neoplasm Recurrence in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benner, SE; Dimery, IW; Esparaz, B; Frenning, D; Guillory-Perez, C; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M | 1 |
| Benedetti, J; Ensley, J; Grunberg, SM; Kuebler, JP; Marshall, ME; Muirhead, MJ; Richert-Boe, KE; Schuller, DE | 1 |
| Bookman, M; Broun, ER; Iseminger, KA | 1 |
| Broun, ER; Iseminger, KA; Lentz, SL; Lincoln, S; Malfetano, JH; Mannel, R; Rose, PG | 1 |
| Armand, JP; Cappelaere, P; Clavel, M; Cognetti, F; de Mulder, PH; Kirkpatrick, A; Schornagel, JH; Vermorken, JB; Verweij, J; Wildiers, J | 1 |
5 trial(s) available for edatrexate and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Phase II study of carboplatin and edatrexate (10-EdAM) with leucovorin rescue for patients with recurrent squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local | 1994 |
Phase II study of edatrexate in advanced head and neck cancer. A Southwest Oncology Group study.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Recurrence, Local | 1994 |
A phase II trial of edatrexate in previously treated ovarian cancer. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Treatment Outcome | 1995 |
A phase II trial of edatrexate in previously treated squamous cell cervical cancer: a Gynecologic Oncology Group study.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Agents; Carcinoma, Squamous Cell; Fanconi Syndrome; Female; Folic Acid Antagonists; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1997 |
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative Group.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Leukopenia; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Thrombocytopenia | 1992 |